EDMONTON, ALBERTA–(Marketwired – May 4, 2017) – Ceapro Inc. (TSX VENTURE:CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused [...]
MONTREAL, QUEBEC–(Marketwired – May 4, 2017) – Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, will release […]